Abstract 1613: Expanded therapeutic window of potent bispecific PD-L1:CD3 T cell engager using a novel best-in-class CD3 binder
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Seattle Children's Research Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148731478
Cites:
Cited by:
Related to:
